Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Carcinogenesis
|
March 12, 2003
Glucocorticoid-like effects of antihepatocarcinogen Rotenone are mediated via enhanced serum corticosterone levels: Molecular Fitting and Receptor Activation Studies
Jihan Youssef, Cem Elbi, Barbour Warren, et al.
The Journal of Biological Chemistry
|
June 24, 2006
Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus
Nisan Bhattacharyya, Klaus Pechhold, Hanief Shahjee, et al.
Cancer Research
|
April 3, 2004
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer
Zhijun Xi, Tove Irene Klokk, Kemal Korkmaz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2004
Molecular chaperones function as steroid receptor nuclear mobility factors
Cem Elbi, Dawn A Walker, Guillermo Romero, et al.
Molecular and Cellular Biology
|
March 4, 2005
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro
Geetha V Rayasam, Cem Elbi, Dawn A Walker, et al.
Cancer Cell International
|
February 17, 2015
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
Sybil M Genther Williams, Apryle M Kuznicki, Paula Andrade, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
March 1, 2006
Chromatin dynamics and the evolution of alternate promoter states
Gordon L Hager, Cem Elbi, Thomas A Johnson, et al.
Science'S STKE : Signal Transduction Knowledge Environment
|
June 24, 2004
A novel in situ assay for the identification and characterization of soluble nuclear mobility factors
Cem Elbi, Dawn A Walker, Marcia Lewis, et al.
Oncotarget
|
October 23, 2018
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
Maria Quanz, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.
Molecular and Cellular Biology
|
December 26, 2006
Ligand-specific dynamics of the androgen receptor at its response element in living cells
Tove I Klokk, Piotr Kurys, Cem Elbi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Carcinogenesis
|
March 12, 2003
Glucocorticoid-like effects of antihepatocarcinogen Rotenone are mediated via enhanced serum corticosterone levels: Molecular Fitting and Receptor Activation Studies
Jihan Youssef, Cem Elbi, Barbour Warren, et al.
The Journal of Biological Chemistry
|
June 24, 2006
Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus
Nisan Bhattacharyya, Klaus Pechhold, Hanief Shahjee, et al.
Cancer Research
|
April 3, 2004
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer
Zhijun Xi, Tove Irene Klokk, Kemal Korkmaz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2004
Molecular chaperones function as steroid receptor nuclear mobility factors
Cem Elbi, Dawn A Walker, Guillermo Romero, et al.
Molecular and Cellular Biology
|
March 4, 2005
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro
Geetha V Rayasam, Cem Elbi, Dawn A Walker, et al.
Cancer Cell International
|
February 17, 2015
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
Sybil M Genther Williams, Apryle M Kuznicki, Paula Andrade, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
March 1, 2006
Chromatin dynamics and the evolution of alternate promoter states
Gordon L Hager, Cem Elbi, Thomas A Johnson, et al.
Science'S STKE : Signal Transduction Knowledge Environment
|
June 24, 2004
A novel in situ assay for the identification and characterization of soluble nuclear mobility factors
Cem Elbi, Dawn A Walker, Marcia Lewis, et al.
Oncotarget
|
October 23, 2018
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
Maria Quanz, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.
Molecular and Cellular Biology
|
December 26, 2006
Ligand-specific dynamics of the androgen receptor at its response element in living cells
Tove I Klokk, Piotr Kurys, Cem Elbi, et al.
Page
of 3